On 2025-02-12, Medicenna Therapeutics Corp. (MDNAF) announced earnings per share of $-0.05 for the fiscal quarter ending 2024-12-31, meeting the average analyst estimate of $-0.05.
The next expected annoucement date for quarterly earnings is 2025-06-25, with an average estimated earnings per share of $-0.05 for the fiscal quarter ending 2025-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-02-12 | 2024-12-31 | $-0.05 | $-0.05 |
| 2024-11-14 | 2024-09-30 | $-0.04 | $-0.04 |
| 2024-07-31 | 2024-06-30 | $-0.05 | $-0.04 |
| 2024-06-26 | 2024-03-31 | $-0.05 | $-0.04 |
| 2024-02-14 | 2023-12-31 | $-0.05 | $-0.05 |
| 2023-11-14 | 2023-09-30 | $-0.05 | $-0.05 |
| 2023-07-28 | 2023-06-30 | $-0.04 | $-0.04 |
| 2023-06-27 | 2023-03-31 | $-0.06 | $-0.04 |
| 2023-02-07 | 2022-12-31 | $-0.06 | $-0.01 |
| 2022-11-04 | 2022-09-30 | $-0.06 | $-0.05 |
| 2022-08-15 | 2022-06-30 | $-0.07 | $-0.06 |
| 2022-06-22 | 2022-03-31 | $-0.08 | $-0.05 |
| 2022-02-09 | 2021-12-31 | $-0.11 | $-0.07 |
| 2021-11-12 | 2021-09-30 | $-0.09 | $-0.12 |
| 2021-08-13 | 2021-06-30 | $-0.08 | $-0.10 |
| 2021-05-28 | 2021-03-31 | $-0.08 | $-0.09 |
| 2021-02-12 | 2020-12-31 | $-0.06 | $-0.08 |
| 2020-11-13 | 2020-09-30 | $-0.04 | $-0.06 |
| 2020-08-04 | 2020-06-30 | -- | $-0.04 |
| 2020-05-15 | 2020-03-31 | -- | $-0.05 |
| 2020-02-13 | 2019-12-31 | -- | $-0.05 |
| 2019-11-05 | 2019-09-30 | -- | $-0.05 |
| 2019-08-09 | 2019-06-30 | -- | $-0.04 |
| 2019-06-25 | 2019-03-31 | -- | $-0.03 |
| 2019-02-14 | 2018-12-31 | -- | $-0.05 |
| 2018-11-13 | 2018-09-30 | -- | $-0.03 |
| 2018-08-13 | 2018-06-30 | -- | $-0.03 |
| 2018-06-27 | 2018-03-31 | -- | $-0.04 |
| 2018-02-12 | 2017-12-31 | -- | $-0.07 |
| 2017-11-10 | 2017-09-30 | -- | $-0.06 |
| 2017-08-08 | 2017-06-30 | -- | $-0.07 |
| 2017-06-16 | 2017-03-31 | -- | $-0.17 |